共 50 条
- [41] Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric CancerONCOLOGIST, 2020, 25 (01): : E68 - E74Moy, Ryan H.Fernandes, Gustavo Dos SantosJonsson, PhilipChou, Joanne F.Basunia, AzfarKu, Geoffrey Y.Chalasani, Sree B.Boyar, Michelle S.Goldberg, ZoeDesai, Avni M.Gabler, AmeliaBerger, Michael F.Tang, Laura H.Hechtman, Jaclyn F.Kelsen, David P.Schattner, MarkIlson, David H.Solit, David B.Taylor, Barry S.Schultz, NikolausCapanu, MarinelaJanjigian, Yelena Y.
- [43] First-line chemotherapy with cisplatin, methotrexate and vinblastine in metastatic bladder cancerTUMORI, 1996, 82 (05) : 453 - 455Pajk, BCufer, TCervek, JZakotnik, B
- [44] Gemcitabine (G) and cisplatin (C) as first-line treatment of metastatic breast cancer (MBC): Results of phase II trial.JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)Karthaus, M.Poddubnaya, I.Churilova, L.Khasanov, R.Veremeychuk, T.Rumyantseva, E.Garin, M.Brichkova, O.Heinrich, B.Heinemann, V.
- [45] Phase II trial of weekly docetaxel/gemcitabine as first-line chemotherapy in patients with locally recurrent or metastatic breast cancerCLINICAL BREAST CANCER, 2006, 6 (06) : 505 - 510O'Shaughnessy, Joyce A.Pluenneke, RobertSternberg, JackKhandelwal, PankajIlegbodu, DesAsmar, Lina
- [46] Impact of paclitaxel, cisplatin, and gemcitabine as first-line chemotherapy in cisplatin-fit and -unfit patients with advanced/metastatic urothelial carcinomaUROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (10) : 731.e25 - 731.e32Katayama, SatoshiKobayashi, YasuyukiTakamoto, AtsushiEdamura, KoheiSadahira, TakuyaIwata, TakehiroNishimura, ShingoSako, TomokoWada, KoichiroAraki, MotooWatanabe, MasamiWatanabe, ToyohikoNasu, Yasutomo
- [47] A phase Ib study evaluating olaratumab in combination with nab-paclitaxel and gemcitabine in first-line treatment of metastatic pancreatic cancer.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)Pelzer, UweBendell, Johanna C.Womack, Mark S.Bahary, NathanMacarulla, TeresaBorazanci, Erkut HasanLevy, Donna EliseMo, GaryRamage, Samuel CowanGarrido-Laguna, Ignacio
- [48] Weekly paclitaxel as first-line chemotherapy for elderly patients with metastatic breast cancer. A multicentre phase II trialEUROPEAN JOURNAL OF CANCER, 2004, 40 (03) : 352 - 357ten Tije, AJSmorenburg, CHSeynaeve, CSparrebooma, ASchothorst, KLCKerkhofs, LGMvan Reisen, LGPMStoter, GBontenbal, MVerweij, J
- [49] GEMCITABINE, DOXORUBICIN AND PACLITAXEL (GAT) AS FIRST-LINE CHEMOTHERAPY FOR METASTATIC BREAST CANCER: AN EXAMPLE OF TRANSLATIONAL RESEARCHANNALS OF ONCOLOGY, 2004, 15 : 18 - 18Passardi, AlessandroTesei, AnnaGianni, LorenzoIbrahim, ToniFabbri, MullerDall'Agata, MoniaZumaglini, FedericaMaltoni, RobertaAmadori, Dino
- [50] A Phase II Trial of Gemcitabine/Carboplatin with or Without Trastuzumab in the First-Line Treatment of Patients with Metastatic Breast CancerCLINICAL BREAST CANCER, 2008, 8 (05) : 425 - 431Yardley, Denise A.Burris, Howard. A., IIISimons, LisaSpigel, David R.Greco, E. AnthonyBarton, John H.Shipley, DiannaDrosick, DavidHainsworth, John D.